Q2PHARMA
Q2pharma specializes in developing small-molecule drugs against multi-drug resistant (MDR) bacteria to be used as adjuvant medication with commonly used antibiotics or a standalone medication. Our lead compound, F19 has shown promise in combating deadly MDR bacterial infections. Whereas antibiotics kill bacteria, as an antivirulent, F19 inhibits bacterial toxin release, allowing the immune system to do its job more effectively. F19 has been shown to potentiate antibiotic efficacy, even to antibiotics that the pathogen is otherwise resistant. Recent experiments have demonstrated F19s potent effects on several of the most common and deadly MDR bacteria.
Q2PHARMA
Industry:
Biopharma Biotechnology Health Care Life Science Pharmaceutical
Founded:
2015-01-01
Address:
Haifa, Hefa, Israel
Country:
Israel
Website Url:
http://www.q2pharma.com
Total Employee:
1+
Status:
Active
Contact:
+972-52-5984109
Email Addresses:
[email protected]
Similar Organizations
ActivePhama
ActivePhama is a Pharmaceutical Company
Blue Ridge BioSciences
A Target Discovery Platform Company
Farbe Firma
Pharmaceutical Formulation Company
Fuji Yakuhin
Pharmaceutical Company
Mits lifesciences
Pharmaceuticals company
Nature's Island
Nutraceutical and botanical
Noven
Pharmaceutical Development
Novo Nordisk Pharmatech
Pharmaceutical company
Palmira Biopharma
Biopharmaceutical company
Pharmapotheca A
A Pharmaceutical company.
Rising Pharmaceuticals
A Pharmaceuticals company.
Saaol Pharma Pvt Ltd
Pharmaceutical Company
SRM INDIA
Pharmaceutical Company
Venistro Biotech
PCD Pharma Company in India
Wudroz Pharmaceuticals
Pharmaceutical Company
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.q2pharma.com
- Host name: viridian03.parklogic.com
- IP address: 172.233.219.49
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
